DK0529300T3 - Hidtil ukendt rekombinant human-IFN-beta, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende det - Google Patents

Hidtil ukendt rekombinant human-IFN-beta, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende det

Info

Publication number
DK0529300T3
DK0529300T3 DK92112427T DK92112427T DK0529300T3 DK 0529300 T3 DK0529300 T3 DK 0529300T3 DK 92112427 T DK92112427 T DK 92112427T DK 92112427 T DK92112427 T DK 92112427T DK 0529300 T3 DK0529300 T3 DK 0529300T3
Authority
DK
Denmark
Prior art keywords
beta
ifn
proportion
oligosaccharide structures
hitherto
Prior art date
Application number
DK92112427T
Other languages
Danish (da)
English (en)
Inventor
Thomas Siklosi
Karl-Eduard Joester
Hans Hofer
Original Assignee
Rentschler Biotech Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6439169&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0529300(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rentschler Biotech Gmbh filed Critical Rentschler Biotech Gmbh
Application granted granted Critical
Publication of DK0529300T3 publication Critical patent/DK0529300T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92112427T 1991-08-27 1992-07-21 Hidtil ukendt rekombinant human-IFN-beta, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende det DK0529300T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4128319A DE4128319A1 (de) 1991-08-27 1991-08-27 Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
DK0529300T3 true DK0529300T3 (da) 1999-06-23

Family

ID=6439169

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92112427T DK0529300T3 (da) 1991-08-27 1992-07-21 Hidtil ukendt rekombinant human-IFN-beta, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende det

Country Status (5)

Country Link
EP (1) EP0529300B1 (fr)
AT (1) ATE172206T1 (fr)
DE (2) DE4128319A1 (fr)
DK (1) DK0529300T3 (fr)
ES (1) ES2121804T3 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US5733761A (en) 1991-11-05 1998-03-31 Transkaryotic Therapies, Inc. Protein production and protein delivery
GB9506051D0 (en) * 1995-03-24 1995-05-10 Univ Singapore Gene expression
AU7130696A (en) * 1995-09-19 1997-04-09 Schering Aktiengesellschaft Combination of beta-interferon for the treatment of prostate cancer
DE19544167A1 (de) * 1995-11-17 1997-05-22 Schering Ag Verwendung von Interferon-ß zur Behandlung von Bronchialkarzinom bei Bestrahlungstherapie
WO1997048808A1 (fr) * 1996-06-19 1997-12-24 Chiron Corporation Production bacterienne d'interferon-beta dans un milieu a faible concentration d'ions de sodium et de potassium
DK1017413T4 (da) * 1997-09-23 2008-03-25 Rentschler Biotech Gmbh Flydende formulering af interferon-beta
FR2791894B1 (fr) * 1999-04-09 2001-07-13 Inst Nat Sante Rech Med Utilisation d'interferon beta dans le traitement de la tumeur d'ewing
US7431921B2 (en) 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
US7144574B2 (en) 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
US6531122B1 (en) 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
WO2002074806A2 (fr) 2001-02-27 2002-09-26 Maxygen Aps Nouvelles molecules de type interferon beta
DK1575531T3 (da) * 2002-09-27 2011-11-21 Biogen Idec Inc Terapier for kronisk inflammatorisk demyeliniserende polyneuropati under anvendelse af interferon-beta
EP1664086B1 (fr) * 2003-09-09 2009-10-28 Novartis Vaccines and Diagnostics, Inc. Separation chromatographique de polypeptides therapeutiques
KR100524871B1 (ko) * 2003-12-04 2005-10-31 씨제이 주식회사 인터페론 베타의 정제방법
CA2553040A1 (fr) 2004-02-02 2005-08-18 Ambrx, Inc. Polypeptides a faisceau a quatre helices (4hb) humains modifies, et leur utilisation
KR100781666B1 (ko) * 2004-11-02 2007-12-03 신영기 인간 인터페론-베타 변이체
BRPI0520498B8 (pt) 2005-08-26 2021-05-25 Ares Trading Sa processo para fabricação de interferon beta humano recombinante glicosilado, e uso de um meio de cultura isento de soro
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3273787D1 (en) * 1981-02-04 1986-11-20 Japan Found Cancer Human interferon-beta gene
JPS58110600A (ja) * 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
US4450103A (en) * 1982-03-01 1984-05-22 Cetus Corporation Process for recovering human IFN-β from a transformed microorganism
IL89662A (en) * 1989-03-19 1997-11-20 Interpharm Lab Ltd Kiryat Weiz Pharmaceutical compositions comprising interferon-beta

Also Published As

Publication number Publication date
ATE172206T1 (de) 1998-10-15
EP0529300B1 (fr) 1998-10-14
DE59209525D1 (de) 1998-11-19
EP0529300A1 (fr) 1993-03-03
DE4128319A1 (de) 1993-03-04
ES2121804T3 (es) 1998-12-16

Similar Documents

Publication Publication Date Title
DK0529300T3 (da) Hidtil ukendt rekombinant human-IFN-beta, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende det
NO930693L (no) Mometasonfuroatmonohydrat, fremgangsmaate for fremstillingav dette og farmasoeytiske preprater
DK0662827T3 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
DE69027989D1 (de) Il-3 MIT ZUSÄTZLICHEN CYSTEINRESTEN UND CHEMISCHE MODIFIKATIONEN DAVON
GR82243B (fr)
ES8702432A1 (es) Procedimiento para la purificacion de una proteina
FI953139A0 (fi) Atovakonia käsittäviä farmaseuttisia koostumuksia
ATE426159T1 (de) Helicobacter pylori nap protein
ES8707964A1 (es) Un metodo para producir acidos tetrabasicos para su utilizacion en la terapia de los seres humanos y en veterinaria.
NO303783B1 (no) Substituerte aminofosfonatderivater og farmas°ytiske preparater derav
NZ234855A (en) 4-substituted-17beta-cyclopropyloxyandrost-5-en-3beta-ol and derivatives; pharmaceutical compositions and preparatory processes
AU3137699A (en) Novel process for the separation of proteins using a Ca ++ containing eluant
ATE81510T1 (de) Loeslichkeits-, reinigungs- und charakterisierungsverfahren fuer proteine aus unloeslichen proteinaggregaten oder proteinkomplexen und diesbezuegliche praeparate.
ES2010283A6 (es) Procedimiento para preparar derivados de somatostatina.
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
DK546489A (da) Thienopyridin-mevalonolactoner, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat omfattende samme
EP0037488A3 (en) Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes
HU905877D0 (en) Process for producing recombinant aprothinine derivatives and pharmaceutical preparatives containing these compounds
ES2114555T3 (es) Nuevo interferon gamma humano recombinado.
EP0242799A3 (en) Cystein-enriched unities of gamma-glutamic acid and beta-alanine, process for their preparation and their use
HUT51647A (en) Process for production of reduced non-glycolized recombined human il under 2
DE69132084D1 (de) Isolierte metallopolypeptide, zusammensetzungen und syntheseverfahren
IT1222427B (it) Procedimento per la purificazione di interferone
GR3004764T3 (fr)
MY106274A (en) Sdk peptides, a preparation process of the same and therapeutic compositions containing them.